Chris Ng, Ph.D.

ZSer|Gates Scholar|Cantab|CUHK

Cambridge, England, United Kingdom

About

During my PhD in pharmacology at Cambridge, I studied protein phase separation and how molecular interactions give rise to higher-order behavior. That systems lens shapes how I approach problems today. I now work at the intersection of science, access, and value, focusing on how innovation translates into evidence, pricing, reimbursement, and real-world patient impact. I’m particularly interested in how data and emerging technologies are reshaping decision-making in healthcare. Outside of work, I’m an explorer and a dreamer. I experiment with AI tools, build small projects as a vibe coder, and think about how technology can augment human judgment. If you’re working on thoughtful ideas in healthcare or data, I’m always open to connecting.

Experience

  • Strategy, Insight and Planning Associate at ZS
    Feb 2026 - Present · 5 mos

  • PhD Candidate at University of Cambridge
    Sep 2021 - Dec 2025 · 4 yrs 4 mos

    Development of Condensates-Enhanced Therapeutics (Supervised by Prof. Laura Itzhaki and Dr. Janet Kumita) - Engineering synthetic bifunctional proteins to revolutionise therapeutic strategies by leveraging protein phase separation.

  • AstraZeneca x Bio-Spark Challenge Solving Fellow at Cambridge Gravity
    Jan 2025 - Jun 2025 · 6 mos

    • Led a cross-functional team of PhD researchers to explore applications of biomolecular condensates in drug discovery. • Conducted technology readiness assessments, competitor landscape reviews, and adoption timeline modelling across 20+ companies. • Identified high-impact opportunities and risks through strategic segmentation and evidence synthesis. • Delivered recommendations that informed AstraZeneca’s exploratory R&D strategy.

  • Team Lead, EnterpriseTECH at Cambridge Judge Entrepreneurship Centre
    Sep 2023 - Jan 2024 · 5 mos

    - Awarded a full scholarship to participate in EnterpriseTECH, an entrepreneurial business course. - led a team of 5 PhD students in developing a market-entry strategy for a biotech start-up - Presented our market-entry proposal in front of more than 100 participants including investors on behalf of my team eventually facilitating a £10K investment decision

  • Research And Development Intern at Codex Genetics
    Aug 2020 - Apr 2021 · 9 mos

    Developed methods for fast screening of neurodegenerative diseases caused by tandem-repeat expansion. Skills acquired: 1. Genomic materials extraction (DNA/RNA/ccfDNA) from different sample types (saliva, blood, FFPE, tissue) 2. PCR operations (TpPCR, mutagenesis-PCR, RT-qPCR) 3. NGS operations (Library preparation)